None
EN
Elevance Health Inc. (NYSE:ELV) Q4 2025 Earnings Call Transcript
[]
Insider Monkey - Free Hedge Fund and Insider Trading DataInsider Monkey – Free Hedge Fund and Insider Trading Data – Free Hedge Fund and Insider Trading Data, Hedge Fund News, Financial Commentaries - News Feed
Elevance Health Inc. (NYSE:ELV) Q4 2025 Earnings Call Transcript January 28, 2026Elevance Health Inc. beats earnings expectations.
Operator: Ladies and gentlemen, thank you for standing by and welcome to the Elevance Health Fourth Quarter Earnings Conference Call.
Elevance Health reported adjusted diluted earnings per share of $3.33 for the fourth quarter and $30.29 for the full year.
We’re taking risk on a category of service basis in some cases, as well as on a whole, you know, health risk basis.
And when I mentioned external growth on the pharmacy side, that’s the integrated, you know, ASO, you know, growth going forward.